Additional antianginal and anti‐ischemic efficacy of mibefradil in patients concomitantly treated with long‐acting nitrates for chronic stable angina pectoris

Background: Mibefradil, a newly approved antihypertensive and antianginal drug, is the first member of a new class of calcium antagonists (CAs), the tetralol derivatives, that selectively blocks T‐type Ca(2+) channels in contrast to classical CAs which, at therapeutic concentrations, block only L‐ty...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Cardiol
Asıl Yazarlar: Frishman, William H., Bittar, Neville, Glasser, Stephen, Habib, Gabriel, Smith, William, Pordy, Robert
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wiley Periodicals, Inc. 2009
Konular:
Clinical Investigations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6656231/
https://ncbi.nlm.nih.gov/pubmed/9669057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960210707
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller